January 4, 2024 by Chain Drug Review
first quarter, Pessina, WBA, Wentworth
Featured Articles, Leading Headlines
DEERFIELD, Ill. — Walgreens Boots Alliance topped Wall Street’s expectations for first quarter sales and earnings, but slashed its quarterly dividend nearly in half. WBA cut its dividend to 25 cents per share from 48 cents per share, reducing the payout for the first time in nearly five decades. New CEO Tim Wentworth, who took
June 29, 2023 by Chain Drug Review
first quarter, Rite Aid, Rite Aid posts better than expected first quarter results
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid Corp. reported a narrower first quarter loss than analysts had projected, and beat revenue forecasts. The company posted an adjusted loss per share loss of 73 cents, which was much better than Wall Street’s estimate of $1.50. Revenue for the period ended June 3 dipped to $5.653 billion from $6.015 billion
May 3, 2023 by Chain Drug Review
CVS, first quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health posted first quarter sales and earnings that topped Wall Street’s forecasts. Revenue for the period ended March 31 rose 11% to $85.3 billion, exceeding analysts’ projected $80.79 billion. Adjusted earnings of $2.20 per share beat the average estimate of $2.09. The strong showing notwithstanding, the company lowered its outlook for
January 5, 2023 by Chain Drug Review
first quarter, WBA
Featured Articles, Leading Headlines
DEERFIELD, Ill. — Walgreens Boots Alliance posted first quarter sales and earnings that topped analysts’ forecasts. WBA reported adjusted earnings per share of $1.16, surpassing the expected $1.14. Revenue for the three-month period ended Nov. 30 was $33.38 billion, ahead of the projected $32.84 billion. Walgreens’ front end sales grew 0.8 percent, with same-store sales
June 23, 2022 by Chain Drug Review
Donigan, first quarter, Rite Aid
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid on Thursday reported a narrower first quarter loss and more revenue than analysts had expected. The company’s adjusted loss per share of 60 cents for the period ended May 28 was smaller than Wall Street’s consensus projection of a 70 cents. Sales of $6.01 billion beat the predicted $5.7 billion. Rite
May 17, 2022 by Chain Drug Review
first quarter, Walmart
Leading Headlines, Retail News
BENTONVILLE, Ark. – Walmart posted mixed results for the first quarter of fiscal 2023. Adjusted earnings per share for the three months ended April 30 were $1.30, well short of the $1.48 that analysts had forecast. The company said inflation hurt the bottom line. Revenue beat analysts’ estimates, rising 2.4% to $141.57 billion. Wall Street
May 4, 2022 by Chain Drug Review
CVS, first quarter, Lynch
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. _ CVS Health reported strong first quarter results, topping analysts’ forecasts for revenue and earnings. Total revenue for the period ended March 31 climbed 11.2% from the year-ago quarter to $76.8 billion, driven by growth across all segments. Wall Street had estimated revenue of $75.3 billion. Adjusted earnings per share rose 8.8% to
January 6, 2022 by Chain Drug Review
Brewer, first quarter, Walgreens, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance far surpassed analysts’ expectations for first quarter profits, as adjusted earnings per share jumped 53.2% to $1.68. Wall Street’s consensus forecast for adjusted EPS was $1.33. With customers flocking to stores for COVID vaccines and tests, sales for the period ended November 30 climbed 7.8% from the year-ago quarter
June 18, 2015 by Chain Drug Review
EnvisionRx, first quarter, fiscal 2016, John Standley, Plenti, RediClinic, Rite Aid, same-store sales, Wellness Store
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. saw sales edge up and earnings decline for its fiscal 2016 first quarter, and the company for the first time gave full-year guidance that includes its pending acquisition of pharmacy benefit manager EnvisionRx. Rite Aid said Thursday that for the first quarter ended May 30, net income totaled
May 1, 2015 by Chain Drug Review
CVS Health, first quarter, fiscal 2015, Larry Merlo, net income, net sales, PBM, pharmacy services, prescription count, retail pharmacy, same-store sales
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Citing a strong performance by its pharmacy benefit management business, CVS Health posted a double-digit sales gain for the first quarter, with adjusted earnings topping Wall Street’s projections. CVS said Friday that net sales for the three months ended March 31 totaled $36.33 billion, up 11.1% from $32.69 billion a year earlier. Sales for CVS’ retail pharmacy business